Effect of dapagliflozin on the triglyceride-glucose index and the atherogenic index of plasma used as markers of atherosclerosis in patients with type 2 diabetes mellitus

ConclusionsDapagliflozin administration lowered the AIP and TyG index in patients with T2DM; this may slow the atherosclerotic process and prevent the associated macrovascular complications.

http://link.springer.com/10.1007/s13410-023-01246-9

Source: International Journal of Diabetes in Developing Countries - September 11, 2023 Category: Endocrinology Source Type: research

More News: Cardiology | Cardiovascular | Dapagliflozin | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Forxiga | Heart | Internal Medicine | Women